{"id":"https://openalex.org/W7224824711","doi":"https://doi.org/10.17480/psk.2026.70.5.413","title":"Challenges and Emerging Strategies in the Development of BET Protein Inhibitors","display_name":"Challenges and Emerging Strategies in the Development of BET Protein Inhibitors","publication_year":2026,"publication_date":"2026-10-30","ids":{"openalex":"https://openalex.org/W7224824711","doi":"https://doi.org/10.17480/psk.2026.70.5.413"},"language":"en","primary_location":{"id":"doi:10.17480/psk.2026.70.5.413","doi":"https://doi.org/10.17480/psk.2026.70.5.413","is_oa":false,"landing_page_url":"https://doi.org/10.17480/psk.2026.70.5.413","pdf_url":null,"source":{"id":"https://openalex.org/S4210195092","display_name":"Yakhak Hoeji","issn_l":"0377-9556","issn":["0377-9556","2383-9457"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["kci-registered"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Yakhak Hoeji","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5139626436","display_name":"The Pharmaceutical Society Of Korea","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"The Pharmaceutical Society Of Korea","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160213307","display_name":"Min Woo Ha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Min Woo Ha","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160215765","display_name":"Jun-Hyeong Seo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jun-Hyeong Seo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160163403","display_name":"Jiho Jeong","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jiho Jeong","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104110444","display_name":"Hye-Yeon Han","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hye-Yeon Han","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5160152942","display_name":"Sumi Lee","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sumi Lee","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.77173281,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"70","issue":"5","first_page":"413","last_page":"423"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12534","display_name":"Protein Degradation and Inhibitors","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12820","display_name":"Chromatin Remodeling and Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bet-proteins","display_name":"BET proteins","score":0.9670000076293945},{"id":"https://openalex.org/keywords/brd4","display_name":"BRD4","score":0.9490000009536743},{"id":"https://openalex.org/keywords/bet-inhibitors","display_name":"BET inhibitors","score":0.7429999709129333},{"id":"https://openalex.org/keywords/bromodomain","display_name":"bromodomain","score":0.628000020980835},{"id":"https://openalex.org/keywords/epigenetic-readers","display_name":"epigenetic reader protein","score":0.734000027179718},{"id":"https://openalex.org/keywords/acetylated-lysine","display_name":"acetylated lysine","score":0.7319999933242798},{"id":"https://openalex.org/keywords/super-enhancers","display_name":"super-enhancers","score":0.7269999980926514},{"id":"https://openalex.org/keywords/p-tefb","display_name":"P-TEFb","score":0.9509999752044678},{"id":"https://openalex.org/keywords/targeted-protein-degradation","display_name":"targeted protein degradation","score":0.7149999737739563},{"id":"https://openalex.org/keywords/multi-target-inhibitors","display_name":"multi-target inhibitors","score":0.8629999756813049},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7540000081062317},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.621999979019165},{"id":"https://openalex.org/keywords/ubiquitin-proteasome-system","display_name":"ubiquitin-proteasome system","score":0.8080000281333923}],"concepts":[{"id":"https://openalex.org/C74401373","wikidata":"https://www.wikidata.org/wiki/Q1829843","display_name":"Bromodomain","level":4,"score":0.9606000185012817},{"id":"https://openalex.org/C2780862049","wikidata":"https://www.wikidata.org/wiki/Q25326844","display_name":"BET inhibitor","level":5,"score":0.767300009727478},{"id":"https://openalex.org/C2779634854","wikidata":"https://www.wikidata.org/wiki/Q18037206","display_name":"BRD4","level":5,"score":0.7505999803543091},{"id":"https://openalex.org/C10679952","wikidata":"https://www.wikidata.org/wiki/Q5308937","display_name":"Druggability","level":3,"score":0.7346000075340271},{"id":"https://openalex.org/C41091548","wikidata":"https://www.wikidata.org/wiki/Q26939","display_name":"Epigenetics","level":3,"score":0.5673999786376953},{"id":"https://openalex.org/C83640560","wikidata":"https://www.wikidata.org/wiki/Q180951","display_name":"Chromatin","level":3,"score":0.4966000020503998},{"id":"https://openalex.org/C64927066","wikidata":"https://www.wikidata.org/wiki/Q36293","display_name":"Histone","level":3,"score":0.4878000020980835},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.4691999852657318},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.4242999851703644},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3928999900817871},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3603000044822693},{"id":"https://openalex.org/C119157956","wikidata":"https://www.wikidata.org/wiki/Q796604","display_name":"Acetylation","level":3,"score":0.34929999709129333},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.32499998807907104},{"id":"https://openalex.org/C2776016237","wikidata":"https://www.wikidata.org/wiki/Q178430","display_name":"Lysine","level":3,"score":0.28630000352859497},{"id":"https://openalex.org/C2778021871","wikidata":"https://www.wikidata.org/wiki/Q648006","display_name":"Footprinting","level":4,"score":0.2809999883174896},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.28040000796318054},{"id":"https://openalex.org/C161624437","wikidata":"https://www.wikidata.org/wiki/Q1988322","display_name":"Small molecule","level":2,"score":0.27900001406669617},{"id":"https://openalex.org/C53645450","wikidata":"https://www.wikidata.org/wiki/Q907093","display_name":"Scaffold protein","level":3,"score":0.2678999900817871},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.26499998569488525},{"id":"https://openalex.org/C107824862","wikidata":"https://www.wikidata.org/wiki/Q616005","display_name":"Binding site","level":2,"score":0.2630000114440918}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.17480/psk.2026.70.5.413","doi":"https://doi.org/10.17480/psk.2026.70.5.413","is_oa":false,"landing_page_url":"https://doi.org/10.17480/psk.2026.70.5.413","pdf_url":null,"source":{"id":"https://openalex.org/S4210195092","display_name":"Yakhak Hoeji","issn_l":"0377-9556","issn":["0377-9556","2383-9457"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["kci-registered"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Yakhak Hoeji","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8999999761581421,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3131397794","https://openalex.org/W4361280607","https://openalex.org/W4211142130","https://openalex.org/W3087130502","https://openalex.org/W4386424206","https://openalex.org/W3083716544","https://openalex.org/W4414770636","https://openalex.org/W4396579266","https://openalex.org/W7166716485","https://openalex.org/W7166663297"],"abstract_inverted_index":{"Bromodomain":[0],"and":[1,14,23,40,72,92,145,166],"extra-terminal":[2],"domain":[3],"(BET)":[4],"proteins":[5,134],"are":[6],"epigenetic":[7],"readers":[8],"that":[9],"recognize":[10],"acetylated":[11],"lysine":[12],"residues":[13],"regulate":[15],"transcriptional":[16,62],"programs":[17],"involved":[18],"in":[19,35],"inflammation,":[20],"cell":[21],"survival,":[22],"tumor":[24],"progression.":[25],"BRD4":[26],"has":[27,57,82],"attracted":[28],"particular":[29],"interest":[30],"because":[31],"of":[32,117,132,170],"its":[33],"role":[34],"super-enhancer":[36],"regulation,":[37],"P-TEFb":[38],"recruitment,":[39],"c-MYC-driven":[41],"oncogenic":[42],"transcription.":[43],"Early":[44],"pan-BET":[45],"inhibitors":[46,98,111],"established":[47],"BET":[48,90,97,107,113,127,133,171],"bromodomains":[49],"as":[50],"druggable":[51],"targets,":[52],"but":[53],"their":[54],"clinical":[55],"translation":[56],"been":[58],"limited":[59,69],"by":[60,104],"broad":[61],"suppression,":[63],"dose-limiting":[64],"toxicities,":[65],"narrow":[66],"therapeutic":[67,102],"windows,":[68],"monotherapy":[70],"efficacy,":[71],"drug":[73,80],"resistance.":[74],"To":[75],"overcome":[76],"these":[77],"limitations,":[78],"BET-targeted":[79,151],"discovery":[81],"shifted":[83],"toward":[84],"domain-":[85],"or":[86,122,163],"protein-selective":[87],"inhibitors,":[88,91],"multi-target":[89,110,164],"targeted":[93],"protein":[94],"degradation.":[95],"Selective":[96],"aim":[99],"to":[100,173],"improve":[101],"selectivity":[103],"exploiting":[105],"context-dependent":[106],"functions,":[108],"whereas":[109],"combine":[112],"blockade":[114],"with":[115,178],"modulation":[116],"kinase":[118],"signaling,":[119],"histone":[120],"deacetylation,":[121],"DNA":[123],"damage":[124],"repair":[125],"pathways.":[126],"degraders":[128,172],"induce":[129],"the":[130,136],"degradation":[131],"through":[135],"ubiquitin-proteasome":[137],"system,":[138],"thereby":[139],"suppressing":[140],"both":[141],"bromodomain-dependent":[142],"chromatin":[143],"binding":[144],"non-bromodomain":[146],"scaffold":[147],"functions.":[148],"Overall,":[149],"next-generation":[150],"therapy":[152],"will":[153],"require":[154],"rational":[155],"indication":[156],"selection,":[157],"biomarker-guided":[158],"patient":[159],"stratification,":[160],"optimized":[161],"combination":[162],"strategies,":[165],"improved":[167],"drug-like":[168],"properties":[169],"achieve":[174],"clinically":[175],"meaningful":[176],"efficacy":[177],"acceptable":[179],"safety.":[180]},"counts_by_year":[],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2026-10-31T00:00:00"}